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Abstract
Background: This study aims to assess, in the population of patients with oral cancer treatment, the influence on 
the quality of life of two protocols of dental treatment: not ruled hospital treatment versus ruled hospital treatment.
Matrial and Methods: A quasi-experimental approach justified on ethical grounds was used. A total of 41 patients 
were included in the control group (not ruled treatment outpatient health center) and 40 in the experimental group 
(ruled hospital treatment). A total of 14 questions to both groups were conducted in three stages: before starting 
cancer treatment, during treatment and after treatment. the proportions of positive responses in groups and differ-
ent times were compared using the chi-square test.
Results: Based on similar situations during cancer treatment were identified as six issues favorable to the experi-
mental group difference. This number rose to nine after finishing oncological treatment.
Conclusions: From our data we can confirm that planned dental treatment performed during the oral cancer treat-
ment produces an improvement in the quality of life in patients with oral cancer.
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Introduction
The term cancer is used to name a group of diseases 
with abnormal and uncontrolled proliferation of cells 
that invade close and distant organs. The incidence rates 
of oral and oropharyngeal cavity cancer have increased 
in recent years. (1) Head and neck carcinomas represent 
5% of all cancers in men and 2% in women; the most 
frequent location of malignant primary tumors of the 
head and neck is the oral cavity (1,2). In the European 
Union, the annual incidence is 48.9 cases per 100,000 
individuals and the mortality is 30.8 cases per 100,000 
inhabitants. The annual prediction worldwide is about 
500,000 new cases. Oropharyngeal carcinomas repre-
sent 40% of head and neck carcinomas (1).
Smoking, alcohol and poor oral hygiene are considered 
the main etiological predisposing factors to the develop-
ment of this malignancy (3). Other predisposing etio-
logical factors, such as infection by the human papillo-
mavirus and the presence of chronic oral inflammation, 
have also been described. The latter two conditions 
play an important role in patients who have never been 
smokers or drinkers (4,5).
The tumor localization and the treatment method, along 
with the stage of the disease, play an essential role not 
only in the prognosis of head and neck cancers, but also 
in the incidence and intensity of side effects (6,7). The 
improvement in the different treatments of head and 
neck cancers have decreased the mortality of these pa-
tients but, on the other hand, the patient must live with 
the different sequelae of this disease, which affect their 
quality of life (8,9).
The aftermath of the surgical resection of the tumor or 
the different sessions of radiotherapy and chemothera-
py affect speech, swallowing, chewing and salivation, 
which in turn result in the nutritional deficit of the pa-
tient. In addition, there will be aesthetic and psycho-
logical consequences (10,11). Some of the side effects 
inherent to cancer treatment, such as oral mucositis, 
xerostomia and caries, which directly affect the qual-
ity of life of patients and can be controlled in the dental 
office (12).
There are several studies within the scientific literature 
in which the beneficial effects of dental therapies in the 
oral health of patients diagnosed with oral cancer and 
subsequent positive impact on their quality of life (10,12-
16) are observed, but there is not enough scientific in-
formation that described the quality of life of patients 
throughout the cancer therapy. For this reason, the aim 
of our study is to assess the influence of regulated dental 
treatment in the quality of life of patients with oral cancer 
during cancer therapy (before, during, after).
Material and Methods
We conducted a quasi-experimental study at the Oral 
and Maxillofacial Surgery Service of Virgen del Rocio 
Hospital in the city of Seville. In mid 2005, the possibil-
ity of incorporating some degree of dental treatment for 
cancer patients in the same hospital was raised (along 
the lines of Kielbassa et al.) (17).
We received the proposal by the hospital management, 
but we needed time to implement the necessary resourc-
es; therefore, we began this study by including patients 
with oral cancer (Squamous Cell Carcinoma) within the 
control group. A total of 41 patients were received from 
September 2005 to September 2006. Once we imple-
mented the necessary resources to provide dental treat-
ment, the 40 patients who comprised the experimental 
group began to receive treatment between October 2006 
and October 2007.
All were treated at Integral Consultation of Oropharyn-
geal Tumors of Virgen del Rocio Hospital in Seville; 
after evaluating their tumor process, were they were 
scheduled to receive cancer treatment. At that time, the 
patients’ state of dental health, habits and oral problems 
were assessed. The patients in the control group were 
informed and advised of the care they should have dur-
ing the chemoradiotherapy treatment. This approach 
was established and monitored at primary care level 
centers (Table 1). The experimental group patients were 
under regulated dental treatment, following the guide-
lines of Kielbassa et al. (26) (Table 1), which was inte-
grated with the treatment of their cancer. This protocol 
was performed in the facilities of the hospital.
The study protocol was approved by the Ethics Com-
mittee of the Virgen del Rocio Hospital (Code USE-
DENT-2005). All patients read and signed the informed 
consent to participate in the study and the guidelines 
outlined in the Declaration of Helsinki for human ex-
perimentation were followed.
The inclusion criteria applied in this study were as fol-
lows: Patients diagnosed with oropharyngeal cancer 
(squamous cell carcinoma) belonging to the Virgen del 
Rocio Hospital in Seville, in need of combined cancer 
treatment, chemoradiotherapy, that have not undergone 
surgery, were not edentulous and demonstrated a Kar-
nosfsky index equal to or greater than 50%.
The exclusion criteria applied in this study were as 
follows: Patients who voluntarily refused the proposal 
made by the specialists of our service and who decided 
to make another treatment alternative to oncologists 
indicated primarily for treatment; Patients who were 
referred to another hospital; Patients who chose not to 
be treated for their disease; Patients who willingly left 
cancer treatment; Patients who refused to submit to any 
part of the study or refused to consent to the scientific 
use of their data by not signing or citing a breach of 
informed consent; patients who died during the study.
To assess the influence of different dental treatments 
that were implemented in the quality of life of patients, 
a questionnaire consisting of a battery of short-answer 
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EXPERIMENTAL GROUP DENTAL TREATMENT
• Teachings of oral hygiene.
• Treatment with fluoride and chlorhexidine, being the two most used principles and most cited in the scientific 
literature on the subject, to control oral diseases secondary to radio-chemoteraphy treatment.
• Scaling and polishing.
• Scaling and root planing.
• Selective carvings, to prevent bedsores in the oral mucosa teeth with sharp edges billed.
• Prosthetic review.
• Fillings.
• Dental extractions.
• Overall patient care as other processes are concerned, where radio-chemothepahy induced candidiasis were 
included.
CONTROL GROUP DENTAL TREATMENT
• Teachings of oral hygiene.
• Use of chlorhexidine and fluoride.
Table 1: List of treatments applied in the hospital to the patients in each group.
questions (yes or no) was performed among patients in 
both groups. The questionnaire was designed to provide 
an idea of the perception of the state of buco-dental 
health and the patients’ experience with oral problems 
experienced during treatment. In addition, four ques-
tions on the general state of the patient and their mood 
were introduced in an effort to drive the individual into 
a more psychic than somatic dynamic.
In each group, the survey was conducted before (one 
month before the chemoradiotherapy), during (when the 
patients had completed 60% of the chemoradiotherapy) 
and after cancer treatment (twelve months after starting 
the study) (Table 2).
The answers to these questionnaires were codified in a 
data file by using SPPS v.11 (IBM, USA) for statistical 
analysis. The descriptive study based on the percentage 
of responses in a positive sense (which does not always 
coincide with “Yes”). To identify differences that could 
be significant between the two groups, the chi square 
test was applied. The Student t test method has been 
used to obtain a comparative mean of positive responses 
in each group and at each time of the study. The authors 
applied the Kolmogorov-Smirnoc test to ensure the nor-
mal distribution of the data.
Results
We begin this section by pointing out the comparability 
between the quality of life of groups of patients before 
treatment of chemoradiotherapy (Fig. 1). The question-
naires collected before starting treatment with chemo-
radiotherapy showed no major differences between the 
1. Do you feel cheerful?
2. Do you want to leave home and relate?
3. Do you want to go out and get ready for an 
event?
4. Have you had toothache during this period?
5. Have you had sore gums during this period?
6. Have you had any teeth to be removed during 
this period?
7. Have you broken a tooth during this period?
8. Have you had bleeding gums during this period?
9. Have you chewed well during this period?
10. Have you had bad taste during this period?
11. Has you had sores in your mouth?
12. Have you had any infection in the mouth?
13. Can you eat normally?
14. Do you think that taking care of your mouth has 
been useful?
Table 2: Questions asked of the patients in the study. Positive re-
sponses to the interest of the study were assessed. For example, in 
question 13, the answer Yes is considered positive, whereas, for ex-
ample, in question 8, the answer was not considered positive.
two groups. Although there were significant differences 
in seven questions (8), in four of them, the differences 
were in favor of the control group.
Regarding the influence of dental treatment on the qual-
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Fig. 1: Survey about the quality of life before cancer treatment according to group (percentage 
(%) of positive responses).
ity of life of patients during chemoradiotherapy (Fig. 2), 
once established cancer treatment (when the patients 
had completed 60% of the chemoradiotherapy) had be-
gun, the questionnaires revealed a positive trend toward 
the regulated dental treatment group, although not all 
questions represented statistically significant differ-
ences. Only 6 questions were identified as significant 
differences, all in favor of the experimental group.
The results of the questions with significant differences 
in each group are shown: Have you had sore gums dur-
ing this period? In the experimental group, 20 patients 
(47.78%) indicated that they had not had sore gums dur-
ing this phase of the chemoradiotherapy. In the con-
trol group, 35 patients (87.5%) reported sore gums at 
this stage; we found significant difference between the 
groups (p <0.001). Another question was have you had 
bleeding gums during this period? In the experimen-
tal group, 7 patients (17.07%) told us they had not had 
bleeding gums during chemoradiotherapy. In the con-
trol group, 35 patients (87.5%) reported having bleed-
ing during this phase (p <0.001). In response to the 
question, Have you chewed well during this period? In 
the experimental group, 21 patients (51.21%) said that 
they were able to chew well at this stage. In the con-
trol group, 6 patients (14.63%) said that they could chew 
well, so we found no significant difference between 
groups (p <0.001). In response to Have you had a bad 
taste during this period? In the experimental group, 18 
patients (43.9%) reported having a bad taste. In the con-
trol group, 39 patients (97.5%) reported having no bad 
taste at this stage of chemoradiotherapy (p <0.001). In 
response to Have you had mouth ulcers during this pe-
riod? In the experimental group, 4 patients (9.75%) had 
ulcers during chemoradiotherapy. In the control group, 
35 patients (87.5%) indicated that they had mouth ulcers, 
finding significant differences between the two groups 
(p <0.001). Another question was Do you think that tak-
ing care of your mouth has served your health well? In 
the experimental group, 34 patients (82.92%) said that it 
helped during chemoradiotherapy. In the control group, 
24 patients (58.53%) indicated that taking care of their 
mouth served them well during this phase (p = 0.01).
Finally, we assessed the influence of dental treatment on 
the quality of life of patients after chemoradiotherapy 
(Fig. 3). After cancer treatment, twelve months after 
starting the study, the number of questions with signifi-
cant differences between both groups increased to nine, 
all in favor of the experimental group.
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Fig. 2: Survey about the quality of life during cancer treatment according to 
group (percentage (%) of positive responses).
Fig. 3: Survey about the quality of life after cancer treatment according to 
group (percentage (%) of positive responses).
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The results of the questions with significant differ-
ences in each group are shown: Do you want to leave 
home and relate? In the experimental group, 38 patients 
(92.68%) said that they want to leave home, in the con-
trol group 31 patients (75.60%) indicated that they want 
to leave home (p = 0.03). Another question was, Do you 
want to go out and get ready for an event? The data in 
this section are similar to those of the previous ques-
tion; in the experimental group, 38 patients responded 
to be ready after chemoradiotherapy and, in the control 
group, 31 patients expressed the desire to go out (p = 
0.03). Further, when asked the question, Have you had a 
toothache during this period?, 7 patients (17.07%) in the 
experimental group stated that they had a toothache af-
ter chemoradiotherapy. In the control group, 23 patients 
(57.5%) had toothaches during this period—we found 
a significant difference between the two groups dur-
ing this phase (p <0.001). With regard to the question, 
Have you had sore gums during this period?, 8 patients 
(19.51%) in the experimental group affirmed that they 
had sore gums during this period after chemoradiother-
apy. In the control group 23 patients (57.5%) had sore 
gums after chemoradiotherapy (p <0.001). Lastly, we 
asked the patients, Have you had bleeding gums during 
this period? In the experimental group, we found a total 
of 7 patients (17.07%), whose gums bled after chemora-
diotherapy. In contrast, in the control group, a total of 
36 patients (87.80%) stated that their gums bled after 
chemoradiotherapy sessions, thus revealing statistically 
significant differences between groups (p <0.001).
Other questions with significant differences between 
the two groups were: Have you chewed well during this 
period? In the experimental group, 27 patients (65.85%) 
indicated that they were able to chew well after chemo-
radiotherapy. In the control group, 11 patients (26.82%) 
said they chewed well during this phase (p <0.001). 
With regard to the question, Have you had bad taste in 
your mouth?, 9 patients (21.95%) in the experimental 
group responded that they had bad taste after chemora-
diotherapy. In comparison, 34 patients (85%) in the con-
trol group said they had no bad taste in this period (p < 
0.001). When asked, Can you eat normally?, 31 patients 
(75.60%) in the experimental group said that they usu-
ally ate after chemoradiotherapy. In the control group, 7 
patients (17.07%) indicated that normally ate after anti-
tumor therapy (p <0.001). In response to the question, 
Do you think that taking care of your mouth has been 
useful?, 36 patients (87.80%) in the experimental group 
answered that it has been useful after chemoradiothera-
py. In the control group, 12 patients (29.26%) answered 
that mouth care has been beneficial (p <0.001).
If we value the evolution of the positive answers in each 
group, then we clearly see how this variable goes from 
11.46 ± 1.3 to 6.41 ± 1.1 in the control group throughout 
the cancer treatment while, in the experimental group, it 
declined from 7.63 ± 1.4 to 11.7 ± 1.8. These differences 
at the beginning and the end of the study were statisti-
cally significant (p < 0.05) between the two groups, as 
well as in the same group between the start and the end 
point of the study.
Discussion
Dentists play a major role in the early detection of oral 
cancer and the maintenance of oral health for patients 
during all stages of this disease, but their role in ad-
dressing this disease should not stop here (10,12-16, 
18,19).
Since 1994, publications have recommended the estab-
lishment of previous dental therapies for cancer treat-
ment in patients with head and neck cancer. Lockhart 
and colleagues recommend a thorough treatment of the 
patient by the dentist to prevent complications during 
and after radiotherapy, thus providing a better quality 
of life (20).
Currently, the consequences and side effects of cancer 
therapies in patients with oral cancer and the effect of 
these therapies in their quality of life are well known 
(8,9,12). Oral mucositis is one of the major side effects 
and is the most important of the chemotherapy and ra-
diotherapy. It hinders patients’ food intake, causes al-
terations in taste and limits speech and chewing ability 
while causing pain, thus decreasing the quality of life 
of patients (21-23). A 2008 report revealed that 80% of 
patients suffering from head and neck carcinoma suffer 
from severe oral mucositis (11).
In 2013, McGuire et al. (22) conducted a systematic re-
view regarding care of the oral cavity in the manage-
ment of oral mucositis in cancer patients. They con-
cluded that there is scientific evidence on the use of oral 
hygiene protocols among patients receiving radiothera-
py and chemotherapy for the prevention of oral mucosi-
tis. They also found that the use of chlorhexidine does 
not prevent mucosal inflammation after cancer thera-
pies. Similar results were obtained by Diaz Sanchez et 
al. (23) in 2015. In their study on the use of bioadhe-
sive chlorhexidine gel in the prevention and treatment 
of mucositis induced by chemotherapy in the head and 
neck, they did not observe the relief of pain and discom-
fort among patients.
In 2015, Barrios et al. (10) conducted a study of 142 pa-
tients on the relationship between oral health and qual-
ity of life of patients suffering from oral cancer surgery, 
radiotherapy and/or chemotherapy. They found that oral 
health and quality of life of patients decreased at least 
six months after cancer treatment. They also recom-
mended the implementation of rehabilitation programs 
to benefit and improve the quality of life of patients. 
These results differ from those obtained in our study, 
although we believe that this is due to the inclusion cri-
teria as they treated patients undergoing surgical ther-
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apy of tumor resections, leading to more complicated 
patient management that affected their oral health and 
quality of life. 
Some studies have shown that the surgical treatment of 
oral cancer increases survival of oral cancer patients, 
but the physical changes caused difficulty with open-
ing the mouth, chewing and speaking, as well as ob-
taining good nutrition and social relations, among other 
aspects, thus directly affecting the patients’ quality of 
life (6,24).
In 2016, Peisker and colleagues (25) conducted a long-
term study on the quality of life of patients with oral 
squamous cell carcinoma undergoing cancer surgery 
with the vascularized reconstruction of a free flap. They 
concluded that the surgery was successful, but the pa-
tient’s quality of life was diminished. So, after cancer 
treatment, they recommended establishing psychologi-
cal therapies, nutritional treatment and rehabilitation as 
part of the multidisciplinary care for the patients.
Quality of life and its measurement values are becom-
ing more important every day in oncological therapies. 
Therefore, several recent studies have been published 
in the scientific literature (25). The specific system to 
objectively quantify the quality of life of patients has 
been and remains difficult, yet there are several valid 
and useful methods in the field of oncology. We found 
the basic questionnaires of the European Organization 
for Research and Treatment of Cancer Quality of Life 
version 3.0 (EORTC QLQ-C30), specifically the head 
and neck modules (EORTC QLQ-HN35 and (FACT-
HN), the generic questionnaire Short Form-36 (SF-36) 
and others (26). The difference between these question-
naires and the one we used in our study is very clear 
and must be highlighted. The questionnaires described 
different measure scales (physical, role, cognitive state, 
state emotional, social, symptoms, sensory, sexuality), 
yet our questionnaire is based on oral health data, sub-
jective information and prior psychological data, dur-
ing and after cancer therapy, that allow us to observe a 
significant improvement in the quality of life of patients 
in this study.
Reviewing the results obtained in the control group, we 
observed that there are statistically significant differ-
ences in improving the quality of life of these patients.
It should be highlighted that no dental treatment was 
performed in the control group; patient follow-up and 
monitoring occurred via the corresponding administra-
tion of toothpaste, mouthwashes and oral hygiene educa-
tion and then derive to the reference ambulatori center. 
Although treatment in this group was limited to advice 
and instruction in mouth care, its beneficial effect on 
the patient has been demonstrated. Therefore, our study 
should not only be assessed on the dental treatment, but 
also on the organization of such treatments around the 
cancer therapy.
In our study, before chemoradiotherapy treatment, re-
search groups had similar situations. During chemora-
diotherapy, the situation changed dramatically. Patients 
in the experimental group had fewer gum symptoms 
(p <0.001); there was a decrease in gums bleeding (p 
<0.001) and less proliferation of oral ulcers. Patients 
chewed better during cancer therapy (p <0.001), which 
could result in better feeding and prevention of possible 
malnutrition.
After chemoradiotherapy, we found several results with 
statistically significant differences in both groups to 
consider. Patients in the experimental group had fewer 
dental symptoms and less gum pain (p <0.001). Patients 
in the control group experienced more bleeding gums 
(p <0.001), while bad taste and the appearance of oral 
ulcers significantly decreased in the experimental group 
(p <0.001). In addition, many of them had agreed that 
they could chew better and consequently had a better 
diet (p <0.001) after cancer therapy. We believe that this 
improvement in the patients’ quality of life is due to the 
regulated dental therapies they underwent and that led 
them to a considerable improvement in the quality of 
life.
The relevance of our study is that it allows us to assess 
the importance of dental treatment on the quality of life 
of patients with oral cancer among two study groups. 
There are no publications in the literature that observe 
the improvement in patients’ quality of life, thanks to 
regulated dental treatment, throughout cancer treatment 
(before, during and after).
Still, our study has some limitations. We only included 
patients undergoing chemoradiotherapy and excluded 
patients undergoing surgical treatment with tumor re-
section and those who were edentulous. The quality 
of life in patients undergoing surgical therapies can be 
highly committed at the nutritional, psychological, so-
cial and aesthetic levels, and although this has not been 
specifically evaluated in our study, our data could be 
extrapolated cautiously in these patients.
In conclusion, we believe that the implementation of 
prevention protocols and the improvement in oral health 
among these patients is necessary. Likewise, treatment 
of the oral pathology of cancer patients should be done 
at a multidisciplinary hospital level in a sphere where 
the dentist could have complete communication with 
the rest of the team involved in this pathology (nurses, 
nutritionists, psychologists, oncologists and oral and 
maxillofacial surgeons).
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